Chapter 9 of 25
Contrast-enhanced CT
Computed tomography, or CT, uses x-rays to create detailed cross-sectional pictures. Contrast injected into a vein can make tumours, vessels and lymph nodes easier to distinguish. CT is useful for many primary sites, neck nodes, bone changes and chest assessment. It is relatively quick, but dental metal can create artefacts that obscure nearby structures.
Tell the team about a previous contrast reaction, kidney disease, pregnancy possibility and relevant medicines. Kidney tests or changes in the scan plan may be needed. Do not stop prescribed medication merely because you read a generic scan leaflet; ask for instructions that apply to the planned contrast and your health.
MRI
Magnetic resonance imaging uses a strong magnet and radio waves rather than x-rays. It can give particularly helpful detail about soft tissues, the tongue, skull base and possible nerve involvement. It is often important in nasopharyngeal and selected sinonasal cancers. Some MRI studies use a contrast agent.
MRI takes longer than many CT scans and requires lying still in a noisy enclosed space. Tell staff about implanted devices, metal fragments, severe claustrophobia and kidney problems. Many implants are compatible under specific conditions, but the radiology team must verify this. Ear protection, explanation and planned support can make the experience easier.
PET-CT
PET-CT combines anatomical imaging with a tracer that reflects activity in tissues, commonly a glucose-like tracer. It may help look for distant disease, a hidden primary, selected recurrences or treatment response. Inflammation and infection can also take up tracer, so a bright area is not automatically cancer. Very small deposits can be missed.
Timing matters after treatment because healing tissues can cause misleading uptake. Follow instructions about fasting, diabetes medicines and activity before the scan. The report should be interpreted with examination, previous imaging and pathology; a suspicious distant finding may need confirmation if it would change a curative treatment plan.
Ultrasound, chest imaging and endoscopy
Ultrasound uses sound waves and is useful for assessing accessible neck nodes or salivary glands and guiding a needle biopsy. It cannot replace CT or MRI for every deep structure. Chest imaging helps evaluate spread, other lung problems or a possible separate lung cancer when clinically indicated.
Endoscopy provides a direct view of the lining and can assess movement or obtain tissue, while imaging shows deeper relationships. These methods complement each other. A normal scan does not necessarily exclude a small mucosal cancer, and a normal visible surface does not exclude deeper extension.
Baseline tests that protect function
Dental assessment before relevant radiation or surgery can identify infection, teeth needing attention and preventive care. Decisions about extractions and healing time should be coordinated with the oncology team. Start dental planning early rather than delaying necessary cancer treatment without a shared plan.
A dietitian reviews intake, weight change and likely support needs. A speech and swallowing therapist may assess swallowing safety and baseline function, sometimes using an instrument-based test. These appointments are part of cancer treatment, not optional extras reserved for severe complications.
Blood counts, kidney function, liver tests and electrolytes help assess treatment fitness. Hearing tests may be appropriate before cisplatin, especially with pre-existing hearing problems or planned exposure. The team may also document thyroid function or other baseline measures depending on the treatment area and proposed medicines.
Does everyone need a PET scan?
No. Some early cancers can be staged adequately with examination and selected CT or MRI. Other situations—such as substantial nodal disease, concern about distant spread or an unknown primary—may make PET-CT useful. A PET scan should be requested because it is likely to change management, not because it is assumed to be the “best scan” for everyone.
If cost or access is difficult, ask which question the scan is meant to answer, whether another approach is acceptable and whether treatment can proceed while arrangements are made. Avoid obtaining additional scans independently; inconsistent timing and unnecessary radiation or incidental findings can complicate decisions.
Understanding results and uncertainty
A report may describe a finding as suspicious, indeterminate or likely benign. These words express uncertainty, not a final diagnosis. Ask whether the finding needs biopsy, follow-up imaging or no further action. The important issue is whether resolving it changes the proposed treatment.
Carry previous scans for comparison and keep the actual images as well as written reports. Ask the team to explain the primary tumour, regional nodes and distant findings separately. This makes the staging discussion clearer and reduces the risk of interpreting any enlarged lymph node or incidental spot as definite cancer.
References and evidence review
- NCI: Head and Neck Cancers fact sheet (2021; current online resource)
- NCI PDQ: Lip and Oral Cavity Cancer Treatment (2025)
- NCI PDQ: Oropharyngeal Cancer Treatment (2025)
- NCI PDQ: Nasopharyngeal Cancer Treatment (2025)
- AAO-HNS: Neck Mass Biopsy patient information (2017)
Evidence/editorial check: 25 October 2026. AI-assisted preparation is distinct from individual physician review. See the linked review policy for source-access limits and review status. Regulatory indications, reimbursement and availability vary by country. Trial results alone do not establish approval everywhere; your treating team should confirm the applicable current guidance.